Pivotal Bioventure Partners
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$524.2M
Focus Areas
3
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Contineum Therapeutics | $524.2M |
| Plexium | — |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Contineum Therapeutics | $524.2M |
| Plexium | — |